Figure 3
From: Using a pharmacogenomic algorithm to guide the treatment of depression

Subjects by advisory category at 8 weeks in the unguided treatment group and the guided treatment group.
From: Using a pharmacogenomic algorithm to guide the treatment of depression
Subjects by advisory category at 8 weeks in the unguided treatment group and the guided treatment group.